Insight Medbotics has clinically tested an MRI-guided robotic device that positions a biopsy device with unprecedented precision and patient comfort, and is now moving to commercialization clearances for both Canada and the USA.

As a precision placement platform, it is able to navigate to a specific point in three dimensions with startling accuracy and repeatability. This is an essential capability in assisting a biopsy procedure that is so innately location dependent.

The system is envisaged to ultimately provide superior imaging, precision biopsy, accurate therapy, and a growing dataset providing prognostic potential